Barclays Initiates Coverage On Tandem Diabetes Care with Equal-Weight Rating, Announces Price Target of $18
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking - Abbott Laboratories (N
Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics - Tandem Diabetes Care (NASDAQ:TNDM), Be